Konruns(SH:603590) Zheng Quan Ri Bao·2026-01-09 12:36Core Viewpoint - Kangchen Pharmaceutical is currently focusing on the domestic market, with export business accounting for a small proportion of overall revenue. However, international expansion is a crucial part of the company's "ten-year strategy" as it aims to align with the trend of integration between the Chinese and international pharmaceutical markets [2]. Group 1 - The company emphasizes that its business is primarily concentrated in the domestic market, with a minor share of revenue coming from exports [2]. - Kangchen Pharmaceutical views international expansion as an essential path for innovative enterprises, indicating a commitment to enhancing its research and development pipeline [2]. - The company plans to actively promote its international strategic layout in response to the growing integration of the Chinese market with the global pharmaceutical market [2].